Vigilant gets CE Mark for 2nd oral cancer test

Vigilant Biosciences' OncAlert oral cancer rapid test has received the CE Mark, which allows the company to market the test in Europe.

Unlike the original OncAlert test, which required the oral rinse to be sent to a lab for analysis, the new test doesn't have to be sent to a lab and shows results within 20 minutes. Currently, neither the OncAlert lab test nor rapid test is available for sale in the U.S.

Page 1 of 116
Next Page